Johnson & Johnson
Pharmaceutical Company and Company
J&J stays true to its diversified model...the company's strategy, with its three broad divisions of medical devices, consumer health and pharmaceuticals. In recent weeks, J&J took minority stakes in Crucell and Elan, two businesses that are active in vaccines and as well as... In this article: Johnson & Johnson, William Weldon, Crucell, Pfizer, Robert Wood Johnson, Wyeth, Novartis, Merck, and Europe |
-
Seeking Alpha | 2 days ago
J&J vs. 10-Year T-Bonds: The Power of Rising Dividends
...bonds, however, a new vision of the power of stocks as income producers comes into view. For example, let's compare Johnson and Johnson (JNJ) common stock with a 10-year US Treasury bond. Today, the dividend yield of JNJ is 3.2%...
In this article: JNJ, Rate of return, US Treasury, and United States
-
Philly.com | 7 days ago
J&J wins dismissal of suit
...& Johnson won a mid-trial dismissal of a lawsuit by a sales representative who said she was fired for blowing the whistle on the company's promotion of the antipsychotic drug Risperdal for unapproved uses. State Superior Court Judge...
In this article: Risperdal, Trenton, Philadelphia, and New Jersey
-
Philly.com | November 09, 2009
J&J to cut 174 Montco jobs
...one day Johnson & Johnson's disclosure that, because of the recession, it would trim about 8,000 jobs around the world. J&J said it expected to save as much as $1.7 billion by 2011 by trimming its 117,000-member workforce by 6 percent to 7...
In this article: Ultram, Department of Industry, Recession, and Topamax
-
USATODAY.com | November 03, 2009
J&J to cut up to 8,000 jobs as part of cost-saving move
...the one that is right for you. J&J to cut up to 8,000 jobs as part of cost-saving move NEW YORK (AP) Johnson & Johnson (JNJ) said Tuesday it will trim layers of management, cut 7,000 to 8,000 jobs, and set other restructuring moves in...
In this article: All rights reserved, Revenue, William Weldon, USA Today, New Brunswick, N.J., NEW YORK, and Associated Press
-
Sydney Morning Herald - Business | November 03, 2009
Johnson & Johnson to cut more than 7000 jobs worldwide
...million. Johnson & Johnson said it expects to take a pre-tax restructuring charge of $US1.1-1.3 billion in the current fourth quarter. J&J, which makes drugs, consumer products and medical devices, has about 117,000 employees worldwide,...
In this article: Tax, Migraine, Topamax, William Weldon, Neutrogena, New Brunswick, New Jersey, and US
-
Reuters | November 03, 2009
J&J to slash 7,000 to 8,000 jobs
...reform and new generic competition for its Risperdal schizophrenia drug and Topamax epilepsy treatment. Instead, it will position J&J to better endure soaring research costs, possible looming overseas price controls on its medicines...
In this article: Risperdal, Topamax, William Weldon, Centralization, Revenue, Cancer, Epilepsy, and Elan Corp
-
CNN | November 03, 2009
Johnson & Johnson to cut up to 8,000 jobs
...structured for sustainable, long-term growth in the health care industry," said William Weldon, J&J's chairman and chief executive. While J&J expects to take a $1.3 billion charge in the fourth quarter, related mostly to severance...
In this article: William Weldon, Unemployment, Cnnmoney.com, Nasdaq, United States, New Brunswick, N.J., and NEW YORK
-
Times Online | November 03, 2009
Johnson & Johnson to axe 8,190 global jobs
Navigation - link to other main sections from here Johnson & Johnson, the US healthcare giant, is cut up to 8,190 jobs from its worldwide workforce as part of a major restructuring designed to save up to $1.7 billion a year. The job...
In this article: Joint venture, Revenue, Risperdal, Alzheimer's, Parkinsons, Migraine, Topamax, William Weldon, and Elan Corp
-
BBC News | November 03, 2009
Johnson & Johnson set to cut jobs
Johnson & Johnson employs 118,700 people worldwide Healthcare firm Johnson & Johnson has said it will cut up to 7% of its global workforce in plans aimed at saving up to $900m (GBP551m) next year. The company, which employs 118,700...
In this article: Revenue, William C. Weldon, and US
-
New Jersey On-Line | November 03, 2009
Johnson & Johnson plans to cut management, simplify structure
...about big, band companies like J&J that fire people. People, business is not the enemy; look at all J&J has done for NJ and society at large over it's history. Out of control government programs are crushing the economy. Their new-employee...
In this article: New Jersey, Revenue, Tax, William Weldon, New Brunswick, and Tallahassee, Fla.
Trends
Loading...
More on Johnson & Johnson
Description from Wikipedia:
Johnson & Johnson (NYSE: JNJ) is a global American pharmaceutical, medical devices and consumer packaged goods manufacturer founded in 1886. Its common stock is a component of the Dow Jones Industrial Average and the company is listed among the Fortune 500. Johnson & Johnson is known for its corporate reputation, consistently ranking at the top of Harris Interactive's National Corporate Reputation Survey, ranking as the world's most respected company by Barron's Magazine, and was the first corporation awarded the Benjamin Franklin Award for Public Diplomacy by the U.S. State Department for its funding of international education programs.
The corporation's headquarters is located in New Brunswick, New Jersey, United States. Its consumer division is located in Skillman, New Jersey. The corporation includes some 250 subsidiary companies with operations in over 57 countries. Its products are sold in over 175 countries.
Johnson & Johnson's brands include numerous household names of medications and first aid supplies. Among its well-known consumer products are the Band-Aid Brand line of bandages, Tylenol medications, Johnson's baby products, Neutrogena skin and beauty products, Clean & Clear facial wash and Acuvue contact lenses.
- Name:
- Johnson & Johnson
- Type:
- Public (NYSE: JNJ)
- Location:
- New Brunswick, NJ
- Region:
- Worldwide
- Founder:
-
- Edward Mead Johnson
- Robert Wood Johnson I
- James Wood Johnson
- Founded:
- 1886
- Stock Symbol:
- JNJ
- Industry:
- Key People:
- William C. Weldon
- Products:
-
- Medical devices
- Pharmaceuticals
- Health care products
- Toiletries
- Revenue:
- USD 61.095 Billion (2007)
- Operating Income:
- USD 13.283 Billion (2007)
- Net Income:
- USD 10.576 Billion (2007)
- Assets:
- USD 80.954 Billion (2007)
- Equity:
- USD 43.319 Billion (2007)
- No. of Employees:
- 119,200 (2008)
- Market Cap:
- USD 184.93 Billion (2008)
Explore everything named Johnson & Johnson...